Harmony Biosciences Secures Exclusive Rights to Promising Narcolepsy Treatment
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), in a strategic move to bolster its portfolio in sleep/wake disorders, has entered into an exclusive licensing agreement with Bioprojet. …
Harmony Biosciences Secures Exclusive Rights to Promising Narcolepsy Treatment Read More